tiprankstipranks
Advertisement
Advertisement

FULC Stock Latest News

Leerink says Agios’ filing reinforces FDA flexibility ahead of Fulcrum update
The FlyLeerink says Agios’ filing reinforces FDA flexibility ahead of Fulcrum update
16d ago
AGIO
FULC
Regulatory Tailwinds and Clinical Momentum Support Buy Rating on Fulcrum Ahead of Key 2Q26 FDA Milestones
PremiumRatings
Regulatory Tailwinds and Clinical Momentum Support Buy Rating on Fulcrum Ahead of Key 2Q26 FDA Milestones
16d ago
FULC
Fulcrum Extends Pociredir Program With Long-Term Sickle Cell Study
PremiumCompany Announcements
Fulcrum Extends Pociredir Program With Long-Term Sickle Cell Study
27d ago
FULC
Fulcrum Therapeutics enters partnership for emergency sickle cell disease care
PremiumThe Fly
Fulcrum Therapeutics enters partnership for emergency sickle cell disease care
28d ago
FULC
Fulcrum Therapeutics Charts Pivotal Path After Earnings Call
PremiumCompany Announcements
Fulcrum Therapeutics Charts Pivotal Path After Earnings Call
2M ago
FULC
Fulcrum Therapeutics price target lowered to $17 from $18 at Truist
PremiumThe FlyFulcrum Therapeutics price target lowered to $17 from $18 at Truist
2M ago
FULC
Fulcrum PIONEER data reinforce pociredir differentiated profile, Wainwright says
Premium
The Fly
Fulcrum PIONEER data reinforce pociredir differentiated profile, Wainwright says
2M ago
FULC
Fulcrum Therapeutics move lower ‘overdone,’ says Stifel
Premium
The Fly
Fulcrum Therapeutics move lower ‘overdone,’ says Stifel
2M ago
FULC
Truist remain buyers of Fulcrum Therapeutics shares on weakness
PremiumThe Fly
Truist remain buyers of Fulcrum Therapeutics shares on weakness
2M ago
FULC
Fulcrum Therapeutics announces results from Phase 1b PIONEER trial of pociredir
PremiumThe Fly
Fulcrum Therapeutics announces results from Phase 1b PIONEER trial of pociredir
2M ago
FULC
Fulcrum Therapeutics reports Q4 EPS (31c), consensus (30c)
PremiumThe Fly
Fulcrum Therapeutics reports Q4 EPS (31c), consensus (30c)
2M ago
FULC
Fulcrum Therapeutics (FULC) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Fulcrum Therapeutics (FULC) Q4 Earnings Cheat Sheet
2M ago
FULC
Pociredir’s Emerging Strength in Sickle Cell Disease Positions FULC for Upside Ahead of 1Q26 Data
PremiumRatingsPociredir’s Emerging Strength in Sickle Cell Disease Positions FULC for Upside Ahead of 1Q26 Data
2M ago
FULC
Fulcrum’s Pociredir Trial Completion Adds a New Catalyst to the Sickle Cell Investment Story
Premium
Company Announcements
Fulcrum’s Pociredir Trial Completion Adds a New Catalyst to the Sickle Cell Investment Story
2M ago
FULC
JPMorgan large/SMid cap biotech analysts hold analyst/industry conference call
Premium
The Fly
JPMorgan large/SMid cap biotech analysts hold analyst/industry conference call
2M ago
AGIO
FULC
De-Risked Efficacy and Clean Safety for Pociredir in Sickle Cell Disease Position FULC for Re-Rating Ahead of 1Q26 Data
PremiumRatings
De-Risked Efficacy and Clean Safety for Pociredir in Sickle Cell Disease Position FULC for Re-Rating Ahead of 1Q26 Data
3M ago
FULC
Fulcrum Therapeutics updates strategy on lead sickle cell therapy
PremiumCompany Announcements
Fulcrum Therapeutics updates strategy on lead sickle cell therapy
3M ago
8K
FULC
Fulcrum Therapeutics initiated with an Overweight at JPMorgan
PremiumThe Fly
Fulcrum Therapeutics initiated with an Overweight at JPMorgan
3M ago
FULC
Fulcrum Therapeutics price target raised to $18 from $14 at Truist
PremiumThe Fly
Fulcrum Therapeutics price target raised to $18 from $14 at Truist
4M ago
FULC
Fulcrum Therapeutics Announces $175 Million Public Offering
PremiumCompany AnnouncementsFulcrum Therapeutics Announces $175 Million Public Offering
4M ago
8K
FULC
Fulcrum Therapeutics 11.85M share Secondary priced at $13.50
Premium
The Fly
Fulcrum Therapeutics 11.85M share Secondary priced at $13.50
4M ago
FULC
Fulcrum Therapeutics price target raised to $7 from $6 at BofA
Premium
The Fly
Fulcrum Therapeutics price target raised to $7 from $6 at BofA
4M ago
FULC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >